Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Human large granular lymphocytes are potent producers of interleukin-1

Nature volume 309, pages 56–59 (1984)Cite this article

Abstract

Natural killer (NK) activity1 against tumour and virus-infected target cells is shown by a subpopulation of peripheral blood mononuclear leukocytes with the morphological features of large granular lymphocytes (LGL)2. The lineage of human LGL is still controversial, as they display surface markers of both T lymphocytes and myelomonocytic cells3. LGL have recently been reported to produce lymphokines such as interleukin-2 (IL-2)4,5 and α- as well as γ-interferons6, functions associated mainly with T cells. To determine whether cytokines associated with other cell lineages are also produced by LGL, we examined whether they might produce a myelomonocyte-associated cytokine such as interleukin-1 (IL-1). IL-1 is a 12–18,000 molecular weight (MW) lymphokine produced by a variety of cell types such as monocytes7, keratinocytes8 and a human dendritic cell line9, which plays a crucial role in immunoregulation and inflammation10,11. Moreover, IL-1 has recently been reported to act synergistically with IL-2 and interferons in boosting LGL-mediated NK activity12. We now show that a subset of highly purified human LGL with NK activity can be stimulated to secrete a soluble factor with the biochemical and biological characteristics of human IL-1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Herberman, R. B. & Ortaldo, J. R. Science 214, 24–30 (1981).

    Article  ADS  CAS  Google Scholar 

  2. Timonen, T., Ortaldo, J. R. & Herberman, R. B. J. exp. Med. 153, 569–582 (1981).

    Article  CAS  Google Scholar 

  3. Ortaldo, J. R., Sharrow, S. O., Timonen, T. & Herberman, R. B. J. Immun. 127, 2401–2409 (1981).

    CAS  PubMed  Google Scholar 

  4. Domzig, W. & Stadler, B. M. in NK Cells and Other Natural Effector Cells (ed. Herberman, R. B.) 409–414 (Academic, New York, 1982).

    Book  Google Scholar 

  5. Kasahara, T., Djeu, J. Y., Dougherty, S. F. & Oppenheim, J. J. J. Immun. 131, 2329–2385 (1983).

    Google Scholar 

  6. Djeu, J. Y. et al. J. exp. Med. 156, 1222–1234 (1982).

    Article  CAS  Google Scholar 

  7. Gery, I. & Waksman, B. H. J. exp. Med. 136, 128–138 (1972).

    Article  CAS  Google Scholar 

  8. Luger, T. A., Stadler, B. M., Katz, S. I. & Oppenheim, J. J. J. Immun. 127, 1493–1498 (1981).

    CAS  PubMed  Google Scholar 

  9. Fisher, R. I., Bostick-Burton, F., Sauder, D. N., Scala, G. & Diehl, V. J. Immun. 130, 2666–2670 (1983).

    CAS  PubMed  Google Scholar 

  10. Oppenheim, J. J. & Gery, I. Immun. Today 3, 113–119 (1982).

    Article  CAS  Google Scholar 

  11. Smith, K. A., Lachman, L. B., Oppenheim, J. J. & Favata, M. F. J. exp. Med. 151, 1551–1556 (1980).

    Article  CAS  Google Scholar 

  12. Dempsey, R. A. et al. J. Immun. 129, 2506–2510 (1982).

    Google Scholar 

  13. Perussia, B., Starr, S., Abraham, S., Fanning, V. & Trinchieri, G. J. Immun. 130, 2133–2141 (1983).

    CAS  PubMed  Google Scholar 

  14. Wands, J. R., Carlson, R. I., Schoemaker, H., Isselbacher, K. J. & Zulewsky, V. R. Jr Proc. natn. Acad. Sci. U.S.A. 78, 1214–1218 (1981).

    Article  ADS  CAS  Google Scholar 

  15. Hanjan, S. N. S., Kearney, J. F. & Cooper, M. D. Clin. Immun. Immunopath. 23, 172–188 (1982).

    Article  CAS  Google Scholar 

  16. Kung, P. C., Goldstein, G., Reinherz, E. L. & Schlossman, S. F. Science 206, 347–349 (1979).

    Article  ADS  CAS  Google Scholar 

  17. Reinherz, E. L., Kung, P. C., Goldstein, G. & Schlossman, S. F. J. Immun. 124, 1301–1302 (1980).

    CAS  PubMed  Google Scholar 

  18. Breard, J. M., Reinherz, E. L., Kung, P. C., Goldstein, G. & Schlossman, S. F. J. Immun. Immunopath. 18, 145 (1980).

    Article  Google Scholar 

  19. Harada, H., Ogata, K., Kasahara, T., Shioiri-Nakano, K. & Kawai, T. J. immun. Meth. 59, 189–198 (1983).

    Article  CAS  Google Scholar 

  20. Timonen, T. et al. Cell. Immun. 72, 178–185 (1982).

    Article  CAS  Google Scholar 

  21. Oppenheim, J. J., Stadler, B. M., Siraganian, R. P., Mage, M. & Mathieson, B. Fedn Proc. 41, 111–116 (1982).

    Google Scholar 

  22. Gary, A. K., Daniele, R. P. & Howell, P. C. J. Immun. 128, 1776–1780 (1982).

    Google Scholar 

  23. Schmidt, J. A., Mizel, S. B., Cohen, D. & Green, I. J. Immun. 128, 2177–2182 (1982).

    CAS  PubMed  Google Scholar 

  24. Farrar, W. L., Mizel, S. B. & Farrar, J. J. J. Immun. 124, 1371–1377 (1980).

    CAS  PubMed  Google Scholar 

  25. Farrar, J. J. et al. Immun. Rev. 63, 129–166 (1982).

    Article  CAS  Google Scholar 

  26. Rosenberg, S. A. & Lipsky, P. E. J. Immun. 126, 1341–1345 (1981).

    CAS  PubMed  Google Scholar 

  27. Postlehwaite, A. E., Lachman, L. B., Mainardi, C. L. & Kang, A. H. J. exp. Med. 152, 801–806 (1983).

    Article  Google Scholar 

  28. Murphy, P. A., Simon, P. L. & Willoughby, W. F. J. Immun. 124, 2498–2501 (1980).

    CAS  PubMed  Google Scholar 

  29. Sztein, M. B. et al. Cell. Immun. 63, 164–176 (1981).

    Article  CAS  Google Scholar 

  30. Mizel, S. B., Rosenstreich, D. L. & Oppenheim, J. J. Cell Immun. 40, 230–235 (1978).

    Article  CAS  Google Scholar 

  31. Stadler, B. M., Dougherty, S. N., Farrar, J. J. & Oppenheim, J. J. J. Immun. 127, 1936–1940 (1981).

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Giuseppe Scala

    Present address: Institute of Biological Chemistry, 2nd University Medical School, via S. Pansini 5, Naples, Italy

Authors and Affiliations

  1. Laboratory of Molecular Immunoregulation, National Cancer Institute–Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA

    Giuseppe Scala & Joost J. Oppenheim

  2. Biological Therapeutics Branch, Biological Response Modifiers Program, National Cancer Institute–Frederick Cancer Research Facility, Frederick, Maryland, 21701, USA

    Paola Allavena, John R. Ortaldo & Ronald B. Herberman

  3. Office of Biologics, National Center for Drugs and Biologics, Food and Drug Administration, Bethesda, Maryland, 20205, USA

    Julie Y. Djeu

  4. Laboratory of Microbiology and Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, 20205, USA

    Tadashi Kasahara

Authors
  1. Giuseppe Scala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Allavena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julie Y. Djeu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tadashi Kasahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John R. Ortaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ronald B. Herberman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joost J. Oppenheim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scala, G., Allavena, P., Djeu, J. et al. Human large granular lymphocytes are potent producers of interleukin-1. Nature 309, 56–59 (1984). https://doi.org/10.1038/309056a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/309056a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing